A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With Schizophrenia
Clinical trial NCT00645099 · COMPLETED
Trial details
- NCT number
- NCT00645099
- Sponsor
- Janssen-Cilag International NV
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2009-04-01
- Enrollment
- 462
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.